GGrantIndex
Sort

10,829 grants matching car t

NeTS: Small: Collaborative Research: Connected Barriers: Vehicle to Barrier Communication and Networking for Single-Vehicle Crash Safety

$180,487
Eylem Ekici · Ohio State University, The · · FY2018 · CSE

MHealth interventions to improve access and coverage of uninsured people with high cardiovascular risk in Argentina

$180,450
Thomas A Gaziano · Brigham And Women'S Hospital · R21 · FY2016 · TW

Development of a novel lymphocyte engineering approach for treatment of vitiligo

$180,400
Xiaoyang Wu · University Of Chicago · R21 · FY2023 · AR

PHASTT: A mobile Personalized HIV and STI Testing Tool for young Black men

$180,360
Hyman Scott · Public Health Foundation Enterprises · K23 · FY2015 · MH

PHASTT: A mobile Personalized HIV and STI Testing Tool for young Black men

$180,360
Hyman Scott · Public Health Foundation Enterprises · K23 · FY2016 · MH

The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis

$180,336
Archita P. Desai · Indiana University Indianapolis · K23 · FY2022 · DK

Neural Markers of the Transition from ADHD risk before age 7 to stable diagnosis

$180,333
Margaret Ann Sheridan · Boston Children'S Hospital · K01 · FY2010 · MH

Defining a therapeutic platform for DIPG with mRNA CAR T cells and microglia inhibition

$180,211
Jessica B Foster · Children'S Hosp Of Philadelphia · K08 · FY2025 · CA

Defining a therapeutic platform for DIPG with mRNA CAR T cells and microglia inhibition

$180,211
Jessica B Foster · Children'S Hosp Of Philadelphia · K08 · FY2022 · CA

Mobile Phone-Based Video Directly Observed Therapy for Tuberculosis

$180,203
Richard S Garfein · University Of California, San Diego · R21 · FY2011 · AI

The Intersection of Personalized Medicine and Implementation Science to Improve Healthcare Utilization in Cirrhosis

$180,179
Archita P. Desai · Indiana University Indianapolis · K23 · FY2021 · DK

Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy

$180,005
Regina M Myers · Children'S Hosp Of Philadelphia · K08 · FY2023 · CA

Mobile Phone Adherence & Prevention Support for People Living with HIV in India

$180,003
Dallas Travis Swendeman · University Of California Los Angeles · R21 · FY2012 · AI

SBIR Phase I: Enabling High-Bandwidth Audio-Visual Connectivity to Vehicles with Public Safety Applications

$180,000
Joshua Hare · Wirover, Inc. · · FY2012 · TIP

Metrics and Singular Integrals

$180,000
Brian Street · University Of Wisconsin-Madison · · FY2018 · MPS

Collaborative Research: Mixed-Autonomy Traffic Networks: Routing Games and Learning Human Choice Models

$180,000
Dorsa Sadigh · Stanford University · · FY2020 · ENG

CSR-EHS: Virtual Node Abstraction Layers for Designing Embedded Systems

$180,000
Nancy A Lynch · Massachusetts Institute Of Technology · · FY2007 · CSE

Collaborative Research: Mixed-Autonomy Traffic Networks: Routing Games and Learning Human Choice Models

$180,000
Ramtin Pedarsani · University Of California-Santa Barbara · · FY2020 · ENG

SBIR Phase I: High Performance Structural Composites with Cellulosic Nanoparticles

$179,995
Elisa Teipel · Essentium Materials Llc · · FY2014 · TIP

Mobile based Nanoplasmonic Quantification of Mtb-derived Exosomes in Serum for Pediatric TB diagnosis

$179,885
Christopher J Lyon · Tulane University Of Louisiana · R21 · FY2020 · EB

Enhancing CAR T Cell Homing Through Glycoengineering

$179,870
Gheath Al-Atrash · University Of Tx Md Anderson Can Ctr · R21 · FY2024 · CA

Collaborative Research: Decentralized Adaptive and Extremum Seeking Control of Robot Manipulators Using Image Processing

$179,488
Miroslav Krstic · University Of California-San Diego · · FY2018 · ENG

Mobile phone surveys for noncommunicable disease risk factors in Uganda

$179,400
Adnan A Hyder · Johns Hopkins University · R21 · FY2017 · TW

HIV-1 passage through the nuclear pore complex

$179,362
Vineet N Kewalramani · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

HERV-K blockade to prevent RAS activation in breast cancer

$179,277
Gary L Johanning · Sunnybay Biotech · R21 · FY2020 · CA